{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:08:25Z","timestamp":1787738905852,"version":"build-2784847793"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00277-025-06597-3","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T03:42:40Z","timestamp":1758166960000},"page":"4637-4647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["T-cell acute lymphoblastic leukemia: therapeutic outcomes in adolescents and young adults"],"prefix":"10.1007","volume":"104","author":[{"given":"Emna","family":"Azza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Ben Othmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maroua","family":"Bahri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roua","family":"Hsasna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raihane","family":"Ben Lakhel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosr","family":"Ben Abdennebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamia","family":"Aissaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"6597_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1182\/blood-2011-04-347872","volume":"119","author":"GM Dores","year":"2012","unstructured":"Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM (2012) Acute leukemia incidence and patient survival among children and adults in the united states, 2001\u20132007. Blood 119:34\u201343. https:\/\/doi.org\/10.1182\/blood-2011-04-347872","journal-title":"Blood"},{"key":"6597_CR2","doi-asserted-by":"publisher","unstructured":"Bleyer A (2021) Important factors improving outcome of young adults with acute lymphoblastic leukemia (ALL). Best Pract Res Clin Haematol 34:101322. https:\/\/doi.org\/10.1016\/j.beha.2021.101322","DOI":"10.1016\/j.beha.2021.101322"},{"key":"6597_CR3","doi-asserted-by":"publisher","first-page":"e577","DOI":"10.1038\/bcj.2017.53","volume":"7","author":"T Terwilliger","year":"2017","unstructured":"Terwilliger T, Abdul-Hay M (2017) Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J 7:e577. https:\/\/doi.org\/10.1038\/bcj.2017.53","journal-title":"Blood Cancer J"},{"key":"6597_CR4","doi-asserted-by":"crossref","unstructured":"Sawyer SM, Azzopardi PS, Wickremarathne D, Patton GC (2018) The age of adolescence\u2026 and young adulthood - authors\u2019 reply. The Lancet Child & Adolescent Health 2:e7","DOI":"10.1016\/S2352-4642(18)30075-0"},{"key":"6597_CR5","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1001\/jamaoncol.2017.5305","volume":"4","author":"SE Siegel","year":"2018","unstructured":"Siegel SE, Stock W, Johnson RH et al (2018) Pediatric-inspired treatment regimens for adolescents and young adults with Philadelphia chromosome\u2013negative acute lymphoblastic leukemia: a review. JAMA Oncol 4:725\u2013734. https:\/\/doi.org\/10.1001\/jamaoncol.2017.5305","journal-title":"JAMA Oncol"},{"key":"6597_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1182\/blood-2018-02-778530","volume":"132","author":"N Boissel","year":"2018","unstructured":"Boissel N, Baruchel A (2018) Acute lymphoblastic leukemia in adolescent and young adults: treat as adults or as children? Blood 132:351\u2013361","journal-title":"Blood"},{"key":"6597_CR7","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1182\/asheducation-2016.1.580","volume":"2016","author":"EA Raetz","year":"2016","unstructured":"Raetz EA, Teachey DT (2016) T-cell acute lymphoblastic leukemia. Hematol Am Soc Hematol Educ Program 2016:580\u2013588","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"6597_CR8","first-page":"1783","volume":"9","author":"MC Bene","year":"1995","unstructured":"Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van\u2019t Veer MB (1995) Proposals for the immunological classification of acute leukemias. European group for the immunological characterization of leukemias (EGIL). Leukemia 9:1783\u20131786","journal-title":"Leukemia"},{"key":"6597_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s002770050276","volume":"74","author":"E Matutes","year":"1997","unstructured":"Matutes E, Morilla R, Farahat N, Carbonell F, Swansbury J, Dyer M, Catovsky D (1997) Definition of acute biphenotypic leukemia. Ann Hematol 74:135\u2013140. https:\/\/doi.org\/10.1007\/s002770050276","journal-title":"Ann Hematol"},{"key":"6597_CR10","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1182\/blood-2016-03-643544","volume":"95","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (2016) The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia. Ann Hematol 95:839\u2013847. https:\/\/doi.org\/10.1182\/blood-2016-03-643544","journal-title":"Ann Hematol"},{"key":"6597_CR11","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/bjh.17172","volume":"100","author":"K Adelborg","year":"2021","unstructured":"Adelborg K, Larsen JB, Hvas AM (2021) Disseminated intravascular coagulation: epidemiology, biomarkers, and management. Ann Hematol 100:1235\u20131246. https:\/\/doi.org\/10.1111\/bjh.17172","journal-title":"Ann Hematol"},{"key":"6597_CR12","doi-asserted-by":"publisher","unstructured":"Olivier-Gougenheim L, Arfeuille C, Suciu S, Sirvent N, Plat G, Ferster A, de Moerloose B, Domenech C, Uyttebroeck A, Rohrlich PS et al (2020) Pediatric randomized trial EORTC CLG 58951: outcome for adolescent population with acute lymphoblastic leukemia. Hematol Oncol. https:\/\/doi.org\/10.1002\/hon.2791","DOI":"10.1002\/hon.2791"},{"key":"6597_CR13","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1200\/JCO.2003.02.053","volume":"21","author":"N Boissel","year":"2003","unstructured":"Boissel N, Auclerc MF, Lh\u00e9ritier V, Perel Y, Thomas X, Leblanc T et al (2003) Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol 21:774\u2013780","journal-title":"J Clin Oncol"},{"key":"6597_CR14","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1001\/jamaoncol.2017.5305","volume":"4","author":"SE Siegel","year":"2018","unstructured":"Siegel SE, Stock W, Johnson RH, Advani A, Muffly L, Douer D et al (2018) Pediatric-inspired treatment regimens for adolescents and young adults with Philadelphia chromosome\u2013negative acute lymphoblastic leukemia. JAMA Oncol 4:725\u2013734","journal-title":"JAMA Oncol"},{"key":"6597_CR15","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s41409-018-0373-4","volume":"54","author":"S Giebel","year":"2019","unstructured":"Giebel S, Marks DI, Boissel N, Baron F, Chiaretti S, Ciceri F et al (2019) Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European working group for adult acute lymphoblastic leukemia (EWALL) and the acute leukemia working party of the European society for blood and marrow transplantation (EBMT). Bone Marrow Transplant 54:798\u2013809","journal-title":"Bone Marrow Transplant"},{"key":"6597_CR16","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.839.839","volume":"122","author":"N G\u00f6kbuget","year":"2013","unstructured":"G\u00f6kbuget N, Beck J, Brandt K, Br\u00fcggemann M, Burmeister T, Diedrich H et al (2013) Significant improvement of outcome in adolescents and young adults (AYAs) aged 15\u201335 years with acute lymphoblastic leukemia (ALL) with a pediatric derived adult ALL protocol: results of 1529 AYAs in 2 consecutive trials of the German multicenter study group for adult ALL (GMALL). Blood 122:839","journal-title":"Blood"},{"key":"6597_CR17","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/leu.2017.265","volume":"32","author":"N Toft","year":"2018","unstructured":"Toft N, Birgens H, Abrahamsson J, Gri\u0161kevi\u010dius L, Hallb\u00f6\u00f6k H, Heyman M et al (2018) Results of NOPHO ALL2008 treatment for patients aged 1\u201345 years with acute lymphoblastic leukemia. Leukemia 32:606\u2013615","journal-title":"Leukemia"},{"key":"6597_CR18","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1182\/blood-2018-10-881961","volume":"133","author":"W Stock","year":"2019","unstructured":"Stock W, Luger SM, Advani AS, Yin J, Harvey RC, Mullighan CG et al (2019) A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403. Blood 133:1548\u20131559","journal-title":"Blood"},{"key":"6597_CR19","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1182\/blood-2014-09-599894","volume":"125","author":"AH Goldstone","year":"2015","unstructured":"Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck G, Fielding AK et al (2015) Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia. Blood 125:2486\u20132496. https:\/\/ashpublications.org\/blood\/article\/125\/16\/2486\/33782","journal-title":"Blood"},{"key":"6597_CR20","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1182\/blood-2014-09-599894","volume":"125","author":"S Chiaretti","year":"2015","unstructured":"Chiaretti S, Fo\u00e0 R (2015) Role of allogeneic hematopoietic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia. Blood 125:2486\u20132496","journal-title":"Blood"},{"key":"6597_CR21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ajh.26066","volume":"96","author":"AM Testi","year":"2021","unstructured":"Testi AM, Canichella M, Vitale A, Piciocchi A, Guarini A, Delia M et al (2021) Adolescent and young adult acute lymphoblastic leukemia: final results of the phase II pediatric-like GIMEMA LAL-1308 trial. Am J Hematol 96:292\u2013301","journal-title":"Am J Hematol"},{"key":"6597_CR22","doi-asserted-by":"publisher","DOI":"10.2217\/ijh-2022-0005","volume":"12","author":"A Hanbali","year":"2023","unstructured":"Hanbali A, Kotb A, Fakih RE, Alfraih F, Shihata N, Rasheed W et al (2023) Improved survival of adolescents and young adults patients with T-cell acute lymphoblastic leukemia. Int J Hematol Oncol 12:IJH42","journal-title":"Int J Hematol Oncol"},{"key":"6597_CR23","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1182\/bloodadvances.2023010303","volume":"7","author":"S Shimony","year":"2023","unstructured":"Shimony S, DeAngelo DJ, Luskin MR (2023) Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia. Blood Adv 7:3994\u20134003. https:\/\/doi.org\/10.1182\/bloodadvances.2023010303","journal-title":"Blood Adv"},{"key":"6597_CR24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41408-023-00881-z","volume":"13","author":"I Aldoss","year":"2023","unstructured":"Aldoss I, Khaled SK, Qin H, Ohanian M, Forman SJ, Pullarkat V (2023) Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma\/leukemia. Blood Cancer J 13:32. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10111357\/","journal-title":"Blood Cancer J"},{"key":"6597_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914646","volume":"24","author":"R Ud Din","year":"2023","unstructured":"Ud Din R, Jiao A, Qiu Y, Mohan AAM, Yuen KC, Wong HT, Wan TMH, Wong POY, Sin CF (2023) Bortezomib is effective in the treatment of T lymphoblastic leukaemia by inducing DNA damage, WEE1 downregulation, and mitotic catastrophe. Int J Mol Sci 24:14646. https:\/\/doi.org\/10.3390\/ijms241914646","journal-title":"Int J Mol Sci"},{"key":"6597_CR26","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/pbc.23297","volume":"57","author":"W Stock","year":"2011","unstructured":"Stock W, Winick NJ, Devidas M et al (2011) Bortezomib combined with reinduction chemotherapy for children with relapsed acute lymphoblastic leukemia: a report from the children\u2019s oncology group (AALL07P1). Pediatr Blood Cancer 57:1008\u20131015. https:\/\/doi.org\/10.1002\/pbc.23297","journal-title":"Pediatr Blood Cancer"},{"key":"6597_CR27","first-page":"321","volume":"140","author":"B Patel","year":"2022","unstructured":"Patel B, Kirkwood AA, Dey A, Vora A, Rasche M, Bloor A et al (2022) CD7 CAR-T cell therapy without genetic manipulation for T-ALL\/LBL: first-in-human phase 1 clinical trial. Blood 140:321\u2013332. https:\/\/ashpublications.org\/blood\/article\/140\/4\/321\/485134","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06597-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06597-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06597-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:30:02Z","timestamp":1761283802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06597-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["6597"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06597-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"31 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical standards of the institutional and\/or national research committee. Approval was obtained from the Ethics Committee of Aziza Othmana Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}